Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/124308
Title: Comparison of 68Ga-FAPI and 18F-DOPA PET/CT in patients with medullary thyroid cancer
Author(s): Hescheler, Daniel A.
Atiyat, Dogan
Lorenz, KerstinLook up in the Integrated Authority File of the German National Library
Heinzel, AlexanderLook up in the Integrated Authority File of the German National Library
Reschke, Philipp
Almaguel, Frankis G.
Petersen, Manuela
Eppard, Elisabeth
Wybranska, Joanna
Wuestemann, Jan
Kreißl, MichaelLook up in the Integrated Authority File of the German National Library
Issue Date: 2026
Type: Article
Language: English
Abstract: Introduction: Accurate staging is paramount for the effective management of medullary thyroid carcinoma (MTC). Imaging cancer-associated fibroblasts utilizing Gallium-68-labeled fibroblast activation protein inhibitors (FAPI) presents a novel approach for molecular imaging across various cancers, including MTC. This study aimed to compare the diagnostic accuracy of FAP-targeted imaging (68Ga-RTX-1363S, abbreviated as 68Ga-FAPI) with the established imaging standard, 18F-DOPA, for the detection of metastases in patients with MTC. Methods: This retrospective study compared 18F-DOPA- and 68Ga-FAPI PET/CT imaging using per-patient and per-lesion analyses in patients with recurrent MTC. Imaging findings were correlated with morphological imaging (CT/MRI/sonography) or histopathology as gold standard. Quantitative assessment included a comparison of standardized uptake values (SUVs) and tumor-to-background ratios (TBRs). Results: Nine patients (mean age 55 years, range 34–80 years) with 62 lesions were included. Compared to 18F-DOPA, 68Ga-FAPI showed significantly higher lesion detection rates for lymph node metastases (true-positive [TP] rate: 100% [8/8] vs. 50% [4/8]; TBR: 10.9 vs. 6.9), lung metastases (TP rate: 85.7% [12/14] vs. 42.9% [6/14]; TBR: 6.1 vs. 3.6), and liver metastases (TP rate: 100% [22/22] vs. 23% [5/22]; TBR: 24.1 vs. 2.7). Conclusion: In direct comparison, 68Ga-FAPI detected a higher number of metastases with higher TBR values. 68Ga-FAPI PET/CT holds promise for improving staging in MTC. However, these findings necessitate confirmation in a larger, prospective study.
URI: https://opendata.uni-halle.de//handle/1981185920/126242
http://dx.doi.org/10.25673/124308
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Journal Title: Frontiers in endocrinology
Publisher: Frontiers Research Foundation
Publisher Place: Lausanne
Volume: 17
Original Publication: 10.3389/fendo.2026.1824054
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
fendo-17-1824054.pdf11.31 MBAdobe PDFThumbnail
View/Open